← FDA Drug Approvals (Drugs@FDA)
MEDROXYPROGESTERONE ACETATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2018-10-12
Drug application
- FDA Application #
ANDA210227- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- MEDROXYPROGESTERONE ACETATE
- Generic name
- MEDROXYPROGESTERONE ACETATE
- Active ingredients
- MEDROXYPROGESTERONE ACETATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- XIROMED
- Manufacturer
- Amneal Pharmaceuticals NY LLC
- First approval
- 2018-10-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown